vs
Side-by-side financial comparison of Arbutus Biopharma Corp (ABUS) and PIONEER POWER SOLUTIONS, INC. (PPSI). Click either name above to swap in a different company.
Arbutus Biopharma Corp is the larger business by last-quarter revenue ($10.7M vs $5.6M, roughly 1.9× PIONEER POWER SOLUTIONS, INC.). Arbutus Biopharma Corp runs the higher net margin — 23.5% vs -24.7%, a 48.2% gap on every dollar of revenue. On growth, Arbutus Biopharma Corp posted the faster year-over-year revenue change (522.2% vs -42.3%). Over the past eight quarters, PIONEER POWER SOLUTIONS, INC.'s revenue compounded faster (30.3% CAGR vs -13.2%).
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
Caterpillar Energy Solutions GmbH, is a mechanical engineering company based in Mannheim, Baden-Württemberg, Germany. It was known as MWM GmbH Motoren-Werke Mannheim (MWM) until November 2013. In 2009 the company was the third-largest producer by revenue of gas and diesel engines.
ABUS vs PPSI — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $10.7M | $5.6M |
| Net Profit | $2.5M | $-1.4M |
| Gross Margin | — | 23.5% |
| Operating Margin | 13.9% | -19.4% |
| Net Margin | 23.5% | -24.7% |
| Revenue YoY | 522.2% | -42.3% |
| Net Profit YoY | 112.7% | -103.8% |
| EPS (diluted) | $0.01 | $-0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $5.6M | ||
| Q3 25 | — | $6.9M | ||
| Q2 25 | $10.7M | $8.4M | ||
| Q1 25 | — | $6.7M | ||
| Q4 24 | — | $9.8M | ||
| Q3 24 | — | $6.4M | ||
| Q2 24 | — | $3.4M | ||
| Q1 24 | — | $3.3M |
| Q4 25 | — | $-1.4M | ||
| Q3 25 | — | $-2.4M | ||
| Q2 25 | $2.5M | $-1.3M | ||
| Q1 25 | — | $-929.0K | ||
| Q4 24 | — | $36.3M | ||
| Q3 24 | — | $-1.1M | ||
| Q2 24 | — | $-2.3M | ||
| Q1 24 | — | $-1.0M |
| Q4 25 | — | 23.5% | ||
| Q3 25 | — | 9.3% | ||
| Q2 25 | — | 15.7% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | — | 23.7% | ||
| Q2 24 | — | 18.9% | ||
| Q1 24 | — | 16.1% |
| Q4 25 | — | -19.4% | ||
| Q3 25 | — | -21.0% | ||
| Q2 25 | 13.9% | -20.4% | ||
| Q1 25 | — | -34.8% | ||
| Q4 24 | — | -11.0% | ||
| Q3 24 | — | -11.1% | ||
| Q2 24 | — | -51.1% | ||
| Q1 24 | — | -52.1% |
| Q4 25 | — | -24.7% | ||
| Q3 25 | — | -34.1% | ||
| Q2 25 | 23.5% | -15.9% | ||
| Q1 25 | — | -13.8% | ||
| Q4 24 | — | 372.1% | ||
| Q3 24 | — | -17.5% | ||
| Q2 24 | — | -67.2% | ||
| Q1 24 | — | -31.2% |
| Q4 25 | — | $-0.12 | ||
| Q3 25 | — | $-0.21 | ||
| Q2 25 | $0.01 | $-0.12 | ||
| Q1 25 | — | $-0.09 | ||
| Q4 24 | — | $3.31 | ||
| Q3 24 | — | $-0.10 | ||
| Q2 24 | — | $-0.21 | ||
| Q1 24 | — | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $37.4M | — |
| Total DebtLower is stronger | $0 | — |
| Stockholders' EquityBook value | $83.0M | $29.3M |
| Total Assets | $103.3M | $35.5M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $37.4M | $18.0M | ||
| Q1 25 | — | $25.8M | ||
| Q4 24 | — | $41.6M | ||
| Q3 24 | — | $3.1M | ||
| Q2 24 | — | $6.5M | ||
| Q1 24 | — | $6.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $0 | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $29.3M | ||
| Q3 25 | — | $30.7M | ||
| Q2 25 | $83.0M | $33.0M | ||
| Q1 25 | — | $34.5M | ||
| Q4 24 | — | $35.4M | ||
| Q3 24 | — | $14.7M | ||
| Q2 24 | — | $15.8M | ||
| Q1 24 | — | $18.1M |
| Q4 25 | — | $35.5M | ||
| Q3 25 | — | $37.6M | ||
| Q2 25 | $103.3M | $39.1M | ||
| Q1 25 | — | $47.5M | ||
| Q4 24 | — | $66.0M | ||
| Q3 24 | — | $40.1M | ||
| Q2 24 | — | $38.0M | ||
| Q1 24 | — | $39.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-15.7M | $-1.0M |
| Free Cash FlowOCF − Capex | — | $-2.2M |
| FCF MarginFCF / Revenue | — | -38.8% |
| Capex IntensityCapex / Revenue | 0.0% | 20.3% |
| Cash ConversionOCF / Net Profit | -6.24× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-8.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-1.0M | ||
| Q3 25 | — | $-817.0K | ||
| Q2 25 | $-15.7M | $-5.5M | ||
| Q1 25 | — | $1.5M | ||
| Q4 24 | — | $-2.1M | ||
| Q3 24 | — | $-2.7M | ||
| Q2 24 | — | $571.0K | ||
| Q1 24 | — | $-1.9M |
| Q4 25 | — | $-2.2M | ||
| Q3 25 | — | $-1.6M | ||
| Q2 25 | — | $-5.6M | ||
| Q1 25 | — | $907.0K | ||
| Q4 24 | — | $-4.6M | ||
| Q3 24 | — | $-3.4M | ||
| Q2 24 | — | $170.0K | ||
| Q1 24 | — | $-2.2M |
| Q4 25 | — | -38.8% | ||
| Q3 25 | — | -23.4% | ||
| Q2 25 | — | -67.0% | ||
| Q1 25 | — | 13.5% | ||
| Q4 24 | — | -46.9% | ||
| Q3 24 | — | -53.0% | ||
| Q2 24 | — | 5.0% | ||
| Q1 24 | — | -65.2% |
| Q4 25 | — | 20.3% | ||
| Q3 25 | — | 11.5% | ||
| Q2 25 | 0.0% | 1.7% | ||
| Q1 25 | — | 8.8% | ||
| Q4 24 | — | 25.4% | ||
| Q3 24 | — | 10.3% | ||
| Q2 24 | — | 11.8% | ||
| Q1 24 | — | 6.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -6.24× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -0.06× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABUS
Segment breakdown not available.
PPSI
| Total Revenue | $4.0M | 70% |
| Other | $1.7M | 30% |
